AJNR Am J Neuroradiol

1. ZHANG S, Lu W, Yao C, Wang J, et al
   (18)F-FDG PET/MR-Based Individual Metabolic Network Analysis for Prognosis Assessment in Temporal and Extratemporal Lobe Refractory Epilepsy.
   AJNR Am J Neuroradiol. 2025 Sep 30:ajnr.A9027. doi: 10.3174/ajnr.A9027.
   

   >> Share

   
   
2. MIDDLEBROOKS EH, Lin C, Pooley RA, Spangler-Bickell MG, et al
   Feasibility of MR-Guided PET Reconstruction in Detection of Focal Cortical Dysplasia.
   AJNR Am J Neuroradiol. 2025 Sep 27:ajnr.A9023. doi: 10.3174/ajnr.A9023.
   

   >> Share

   
   

   
   Ann Nucl Med

3. JIAMING S, Jiani Y
   Comment on the impact of anti-HER2 therapy on the accuracy of 68 Ga-HER2-affibody PET/CT imaging in metastatic breast cancer.
   Ann Nucl Med. 2025 Oct 3. doi: 10.1007/s12149-025-02111.
   

   >> Share

   
   
4. SEBAN RD, Champion L, Buvat I
   Response to "Beyond glucose uptake: rethinking PET/CT and hematologic markers for immune profiling in early breast cancer".
   Ann Nucl Med. 2025 Oct 2. doi: 10.1007/s12149-025-02115.
   

   >> Share

   
   
5. WU D, Jiang Q, Shen G, Gao X, et al
   Quantitative analysis of striatal subregional asymmetry on (99m)Tc-TRODAT-1 SPECT and clinical correlations with UPDRS subscales in Parkinson's disease.
   Ann Nucl Med. 2025 Oct 1. doi: 10.1007/s12149-025-02112.
   

   >> Share

   
   
6. ALTUNDAG K
   Beyond glucose uptake: rethinking PET/CT and hematologic markers for immune profiling in early breast cancer.
   Ann Nucl Med. 2025 Sep 30. doi: 10.1007/s12149-025-02114.
   

   >> Share

   
   

   
   Brain

7. ANAND C, Abdelnour F, Sipes B, Ma D, et al
   Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome.
   Brain. 2025 Jul 9:awaf179. doi: 10.1093.
   

   >> Share

   
   

   
   Clin Nucl Med

8. KIM DW, Park SA, Kim MH
   18 F-PSMA-1007 and 18 F-FDG PET/CT Findings of Pulmonary Tuberculosis Mimicking Malignancy.
   Clin Nucl Med. 2025 Sep 26. doi: 10.1097/RLU.0000000000006137.
   

   >> Share

   
   
9. PUROHIT P, Preet K, Mittal BR, Kumar R, et al
   Rare Presentation of Lymphomatoid Granulomatosis With CNS, Pulmonary, and Musculoskeletal System Involvement on 18F-FDG PET/CT.
   Clin Nucl Med. 2025 Sep 26. doi: 10.1097/RLU.0000000000005944.
   

   >> Share

   
   
10. DAMIAN A, Kramer V, Servente L, Ferrando R, et al
    Benign Bone Lesion With Incidental 18F-PR04.MZ Uptake on PET/CT in a Patient With Parkinson's Disease.
    Clin Nucl Med. 2025 Sep 30. doi: 10.1097/RLU.0000000000006093.
    

    >> Share

    
    

    
    Curr Opin Cardiol

11. KWONG RY, Heydari B, Bernhard B
    A practical review of stress perfusion cardiac magnetic resonance imaging for the management of coronary artery disease.
    Curr Opin Cardiol. 2025;40:448-458.
    

    >> Share

    
    

    
    IEEE Trans Med Imaging

12. MARQUARDT N, Hengsbach T, Mauritz M, Wirth B, et al
    Motion simulation of radio-labeled cells in whole-body positron emission tomography.
    IEEE Trans Med Imaging. 2025;PP.
    

    >> Share

    
    

    
    J Nucl Cardiol

13. PASCALE R, Fernandez-Hidalgo N, Tazza B, Bartoletti M, et al
    How to manage patients receiving long-term suppressive antibiotic treatment for infective endocarditis: the role of [18F]-FDG-PET/CT imaging - An international multidisciplinary survey.
    J Nucl Cardiol. 2025 Sep 27:102505. doi: 10.1016/j.nuclcard.2025.102505.
    

    >> Share

    
    
14. KHAN MS, Perumalla HS, Modi K, Asif T, et al
    National Trends in Radiopharmaceutical Use for the Diagnosis of Cardiac Amyloidosis from 2019-2024.
    J Nucl Cardiol. 2025 Sep 26:102502. doi: 10.1016/j.nuclcard.2025.102502.
    

    >> Share

    
    

    
    J Nucl Med

15. KUJAWSKI M, Aniogo E, Wong P, Hui S, et al
    Combination Image-Guided and Antibody-Targeted alpha-Therapy Before Targeted Immunotherapy for Treatment of Solid Tumors.
    J Nucl Med. 2025;66:1605-1611.
    

    >> Share

    
    
16. UPRIMNY C, von Guggenberg E, Sviridenko A, Bayerschmidt S, et al
    Diagnostic Performance of the (68)Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Advanced Medullary Thyroid Cancer and Other Neuroendocrine Tumors.
    J Nucl Med. 2025 Aug 28:jnumed.125.269863. doi: 10.2967/jnumed.125.269863.
    

    >> Share

    
    
17. MURTHY V, Kimura K, Theus L, Nguyen A, et al
    Prognostic Value of AI-Assisted Lesion Tracking on End-of-Treatment PSMA PET in mCRPC Patients Treated with (177)Lu-PSMA: A Retrospective, Single-Center Study.
    J Nucl Med. 2025 Sep 25:jnumed.125.269971. doi: 10.2967/jnumed.125.269971.
    

    >> Share

    
    
18. DOYON V, Sarrhini O, Loignon-Houle F, Toussaint M, et al
    PET Imaging of the Human Brain with Microvolumetric Spatial Resolution.
    J Nucl Med. 2025 Sep 25:jnumed.124.268809. doi: 10.2967/jnumed.124.268809.
    

    >> Share

    
    
19. LAZAR A, Matassa G, Hammami DW, Chiti A, et al
    Diagnostic Reliability and Clinical Impact of [(11)C]Choline PET/CT for Detecting Hyperfunctioning Parathyroid Glands.
    J Nucl Med. 2025 Sep 25:jnumed.125.270664. doi: 10.2967/jnumed.125.270664.
    

    >> Share

    
    
20. CIUCIULKAITE I, Zuccotti GA, Jallo C, Hautzel H, et al
    Thyroid Hormone Withdrawal Yields Higher (131)I Absorbed Dose to Metastases Than rhTSH Stimulation in Differentiated Thyroid Cancer: Evidence from a Large (124)I PET/CT Dosimetry Cohort.
    J Nucl Med. 2025 Sep 25:jnumed.125.270391. doi: 10.2967/jnumed.125.270391.
    

    >> Share

    
    
21. HOYVIK AJK, Stenberg VY, Liukaityte R, Repetto-Llamazares A, et al
    Optimizing [(212)Pb]Pb-AB001 Radiopharmaceutical Therapy Schedules in PSMA-Positive Subcutaneous Prostate Cancer Xenografts.
    J Nucl Med. 2025 Oct 3:jnumed.125.270444. doi: 10.2967/jnumed.125.270444.
    

    >> Share

    
    
22. SARTOR O, Emmett L, Herrmann K
    Resisting RECIST: PSMA PET and Regulatory Change in Prostate Cancer.
    J Nucl Med. 2025 Oct 3:jnumed.125.271144. doi: 10.2967/jnumed.125.271144.
    

    >> Share

    
    
23. MOSTAFAPOUR S, van Sluis J, van Snick JH, Noordzij W, et al
    Influence of Ultra-Low-Dose CT on PET Image Quantification and Visual Assessment.
    J Nucl Med. 2025 Oct 3:jnumed.124.269188. doi: 10.2967/jnumed.124.269188.
    

    >> Share

    
    
24. GOLDSTEIN DS, Holmes C, Ding YS
    Multitracer PET to Assess Cardiac Sympathetic Innervation and Vesicular Storage in Lewy Body Diseases.
    J Nucl Med. 2025 Oct 3:jnumed.125.269840. doi: 10.2967/jnumed.125.269840.
    

    >> Share

    
    

    
    Lancet

25. FRISONI GB, Hansson O, Nichols E, Garibotto V, et al
    New landscape of the diagnosis of Alzheimer's disease.
    Lancet. 2025;406:1389-1407.
    

    >> Share

    
    

    
    Nucl Med Commun

26. GUO YH, Tian Y, Huang JW, Liu AJ, et al
    Prognostic value of tumor dissemination feature based on baseline 18F-FDG PET/CT in patients with newly diagnosed multiple myeloma.
    Nucl Med Commun. 2025 Sep 25. doi: 10.1097/MNM.0000000000002059.
    

    >> Share

    
    

    
    Nuklearmedizin

27. MIKSCH J, Yousefzadeh-Nowshahr E, Hardiansyah D, Glatting G, et al
    First clinical application of silicon-based [(1)(8)F]siPSMA-14 in prostate cancer patients: A proof-of-concept study.
    Nuklearmedizin. 2025;64:285-293.
    

    >> Share

    
    
28. AMBULKAR KS, Shah R, Lila A, Sharma A, et al
    Outcomes of 68Ga-NODAGA-Exendin-4 PET/CT Guided Surgical Management of Insulinomas in MEN1: A Preliminary Study.
    Nuklearmedizin. 2025;64:301-307.
    

    >> Share

    
    
29. MANDIC A, Kraljevic I, Skoric Polovina T, Zibar Tomsic K, et al
    Diagnostic Performance of 99 mTc-Sestamibi SPECT/CT and 18F-Choline PET/CT in Locating Hyperfunctioning Parathyroid Glands in Patients with Primary Hyperparathyroidism.
    Nuklearmedizin. 2025;64:308-312.
    

    >> Share

    
    
30. KALANTARI F, Rendl G, Hecht S, Pirich C, et al
    Atypical local laryngeal cancer recurrence mimicking thyroid uptake on 18F-FDG PET/CT.
    Nuklearmedizin. 2025;64:316-317.
    

    >> Share

    
    
31. CHIKASUE T, Kurata S, Edamitsu S, Koganemaru M, et al
    Central Conducting Lymphatic Abnormalities in Noonan Syndrome Identified Using SPECT/CT Lymphoscintigraphy.
    Nuklearmedizin. 2025 Sep 30. doi: 10.1055/a-2695-8007.
    

    >> Share

    
    

    
    Phys Med Biol

32. CHU H, Lee S, Cates JW, Heller R, et al
    Silicon-based 3D beta ray radiopharmaceutical trackers: a Monte Carlo computational study.
    Phys Med Biol. 2025 Sep 25. doi: 10.1088/1361-6560.
    

    >> Share

    
    
33. WANG H, Zou W, Wang J, Li J, et al
    Pseudo PET synthesis from CT based on deep neural networks.
    Phys Med Biol. 2025 Sep 24. doi: 10.1088/1361-6560.
    

    >> Share

    
    

    
    PLoS One

34. TSUJIMOTO M, Watanabe M, Nogami K, Kawai H, et al
    Optimization of acquisition time and reconstruction parameters for quantitative single-photon emission computed tomography/computed tomography using iodine-123 metaiodobenzylguanidine.
    PLoS One. 2025;20:e0330655.
    

    >> Share

    
    

    
    Semin Nucl Med

35. KABUNDA J, Ndlovu H, Singh K, Sibiya S, et al
    Nectin-4, Bladder Cancer, and Nuclear Medicine: A Theranostic Frontier.
    Semin Nucl Med. 2025 Sep 26:S0001-2998(25)00118.
    

    >> Share

    
    
36. THIENTUNYAKIT T, Muangpaisan W, Minoshima S
    Corrigendum to '18F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in The Era of Anti-Amyloid Treatment' [Seminar in Nuclear Medicine volume 55 (2025):526 -537/Article number YSNUC_51208].
    Semin Nucl Med. 2025 Sep 25:S0001-2998(25)00116.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share